New Insights into the Mechanisms of Epithelial-mesenchymal Transition and Implications for Cancer

Overview

Journal Nat Rev Mol Cell Biol

Specialties Cell Biology
Molecular Biology

Date 2018 Nov 22

PMID 30459476

Citations 1739

Authors

Anushka Dongre

Robert A Weinberg

Affiliations

Soon will be listed here.

Abstract

Epithelial-mesenchymal transition (EMT) is a cellular programme that is known to be crucial for embryogenesis, wound healing and malignant progression. During EMT, cell-cell and cell-extracellular matrix interactions are remodelled, which leads to the detachment of epithelial cells from each other and the underlying basement membrane, and a new transcriptional programme is activated to promote the mesenchymal fate. In the context of neoplasias, EMT confers on cancer cells increased tumour-initiating and metastatic potential and a greater resistance to elimination by several therapeutic regimens. In this Review, we discuss recent findings on the mechanisms and roles of EMT in normal and neoplastic tissues, and the cell-intrinsic signals that sustain expression of this programme. We also highlight how EMT gives rise to a variety of intermediate cell states between the epithelial and the mesenchymal state, which could function as cancer stem cells. In addition, we describe the contributions of the tumour microenvironment in inducing EMT and the effects of EMT on the immunobiology of carcinomas.

Citing Articles

SERPINI1 serves as a biomarker promoting cell proliferation and invasion in hepatocellular carcinoma.

Han Y, Wang G, Han E, Yang S, Zhao R, Lan Y Cancer Cell Int. 2025; 25(1):88.

PMID: 40082896 PMC: 11908049. DOI: 10.1186/s12935-025-03716-y.

Mesothelioma cell heterogeneity identified by single cell RNA sequencing.

Wu L, Wang Z, Zia A, Kelley S, de Perrot M Sci Rep. 2025; 15(1):8725.

PMID: 40082554 PMC: 11906801. DOI: 10.1038/s41598-025-92542-3.

Identifying distinct prognostic and predictive contributions of tumor epithelium versus tumor microenvironment in colorectal cancer.

Yang M, Nebozhyn M, Schell M, Gandhi N, Pflieger L, Loboda A BMC Cancer. 2025; 25(1):441.

PMID: 40075322 PMC: 11899100. DOI: 10.1186/s12885-025-13829-2.

The feedback loop between miR-222-3p and ZEB1 harnesses metastasis in renal cell carcinoma.

Wang F, Li L, Sun X, Cai X, Wang J, Luo H Cell Death Discov. 2025; 11(1):97.

PMID: 40074730 PMC: 11903659. DOI: 10.1038/s41420-025-02385-0.

CYP2A6 suppresses hepatocellular carcinoma via inhibiting SRC/Wnt/β-Catenin pathway.

Liu Y, Feng L, Zhang W, Zhang X, Shao L, Zhao X Acta Pharmacol Sin. 2025; .

PMID: 40069491 DOI: 10.1038/s41401-025-01524-8.

References

Nieto M . Epithelial-Mesenchymal Transitions in development and disease: old views and new perspectives. Int J Dev Biol. 2009; 53(8-10):1541-7. DOI: 10.1387/ijdb.072410mn. View

Kalluri R, Weinberg R . The basics of epithelial-mesenchymal transition. J Clin Invest. 2009; 119(6):1420-8. PMC: 2689101. DOI: 10.1172/JCI39104. View

Ye X, Tam W, Shibue T, Kaygusuz Y, Reinhardt F, Eaton E . Distinct EMT programs control normal mammary stem cells and tumour-initiating cells. Nature. 2015; 525(7568):256-60. PMC: 4764075. DOI: 10.1038/nature14897. View

Rhim A, Mirek E, Aiello N, Maitra A, Bailey J, McAllister F . EMT and dissemination precede pancreatic tumor formation. Cell. 2012; 148(1-2):349-61. PMC: 3266542. DOI: 10.1016/j.cell.2011.11.025. View

Krebs A, Mitschke J, Losada M, Schmalhofer O, Boerries M, Busch H . The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer. Nat Cell Biol. 2017; 19(5):518-529. DOI: 10.1038/ncb3513. View

Mani S, Guo W, Liao M, Eaton E, Ayyanan A, Zhou A . The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 2008; 133(4):704-15. PMC: 2728032. DOI: 10.1016/j.cell.2008.03.027. View

Singh A, Settleman J . EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene. 2010; 29(34):4741-51. PMC: 3176718. DOI: 10.1038/onc.2010.215. View

Morel A, Lievre M, Thomas C, Hinkal G, Ansieau S, Puisieux A . Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS One. 2008; 3(8):e2888. PMC: 2492808. DOI: 10.1371/journal.pone.0002888. View

Tam W, Weinberg R . The epigenetics of epithelial-mesenchymal plasticity in cancer. Nat Med. 2013; 19(11):1438-49. PMC: 4190672. DOI: 10.1038/nm.3336. View

10.

Shibue T, Weinberg R . EMT, CSCs, and drug resistance: the mechanistic link and clinical implications. Nat Rev Clin Oncol. 2017; 14(10):611-629. PMC: 5720366. DOI: 10.1038/nrclinonc.2017.44. View

11.

Lambert A, Pattabiraman D, Weinberg R . Emerging Biological Principles of Metastasis. Cell. 2017; 168(4):670-691. PMC: 5308465. DOI: 10.1016/j.cell.2016.11.037. View

12.

Kalluri R . EMT: when epithelial cells decide to become mesenchymal-like cells. J Clin Invest. 2009; 119(6):1417-9. PMC: 2689122. DOI: 10.1172/JCI39675. View

13.

Olumi A, Grossfeld G, Hayward S, Carroll P, Tlsty T, Cunha G . Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res. 1999; 59(19):5002-11. PMC: 3300837. DOI: 10.1186/bcr138. View

14.

Kojima Y, Acar A, Eaton E, Mellody K, Scheel C, Ben-Porath I . Autocrine TGF-beta and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblasts. Proc Natl Acad Sci U S A. 2010; 107(46):20009-14. PMC: 2993333. DOI: 10.1073/pnas.1013805107. View

15.

Stepaniak P, Furst J, Woodard D . Anabolic steroids as a countermeasure against bone demineralization during space flight. Aviat Space Environ Med. 1986; 57(2):174-8. View

16.

Terry S, Savagner P, Ortiz-Cuaran S, Mahjoubi L, Saintigny P, Thiery J . New insights into the role of EMT in tumor immune escape. Mol Oncol. 2017; 11(7):824-846. PMC: 5496499. DOI: 10.1002/1878-0261.12093. View

17.

Dongre A, Rashidian M, Reinhardt F, Bagnato A, Keckesova Z, Ploegh H . Epithelial-to-Mesenchymal Transition Contributes to Immunosuppression in Breast Carcinomas. Cancer Res. 2017; 77(15):3982-3989. PMC: 5541771. DOI: 10.1158/0008-5472.CAN-16-3292. View

18.

Lamouille S, Xu J, Derynck R . Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol. 2014; 15(3):178-96. PMC: 4240281. DOI: 10.1038/nrm3758. View

19.

Bierie B, Pierce S, Kroeger C, Stover D, Pattabiraman D, Thiru P . Integrin-β4 identifies cancer stem cell-enriched populations of partially mesenchymal carcinoma cells. Proc Natl Acad Sci U S A. 2017; 114(12):E2337-E2346. PMC: 5373369. DOI: 10.1073/pnas.1618298114. View

20.

Grande M, Sanchez-Laorden B, Lopez-Blau C, de Frutos C, Boutet A, Arevalo M . Snail1-induced partial epithelial-to-mesenchymal transition drives renal fibrosis in mice and can be targeted to reverse established disease. Nat Med. 2015; 21(9):989-97. DOI: 10.1038/nm.3901. View